Japan · Delayed Price · Currency is JPY Mizuho Medy Statistics
Total Valuation
Mizuho Medy has a market cap or net worth of JPY 33.03 billion. The enterprise value is 19.97 billion.
| Market Cap | 33.03B |
| Enterprise Value | 19.97B |
Important Dates
The last earnings date was Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | Dec 29, 2026 |
Share Statistics
Mizuho Medy has 19.05 million shares outstanding. The number of shares has decreased by -20.00% in one year.
| Current Share Class | 19.05M |
| Shares Outstanding | 19.05M |
| Shares Change (YoY) | -20.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 28.58% |
| Owned by Institutions (%) | 5.28% |
| Float | 13.12M |
Valuation Ratios
The trailing PE ratio is 10.24.
| PE Ratio | 10.24 |
| Forward PE | n/a |
| PS Ratio | 3.05 |
| PB Ratio | 1.78 |
| P/TBV Ratio | 1.78 |
| P/FCF Ratio | 13.48 |
| P/OCF Ratio | 12.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.50, with an EV/FCF ratio of 8.15.
| EV / Earnings | 6.19 |
| EV / Sales | 1.85 |
| EV / EBITDA | 4.50 |
| EV / EBIT | 4.79 |
| EV / FCF | 8.15 |
Financial Position
The company has a current ratio of 13.22
| Current Ratio | 13.22 |
| Quick Ratio | 10.56 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 18.04% and return on invested capital (ROIC) is 53.54%.
| Return on Equity (ROE) | 18.04% |
| Return on Assets (ROA) | 12.80% |
| Return on Invested Capital (ROIC) | 53.54% |
| Return on Capital Employed (ROCE) | 21.26% |
| Weighted Average Cost of Capital (WACC) | 6.94% |
| Revenue Per Employee | 56.05M |
| Profits Per Employee | 16.72M |
| Employee Count | 193 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.06 |
Taxes
In the past 12 months, Mizuho Medy has paid 1.22 billion in taxes.
| Income Tax | 1.22B |
| Effective Tax Rate | 27.47% |
Stock Price Statistics
The stock price has increased by +9.75% in the last 52 weeks. The beta is 0.49, so Mizuho Medy's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +9.75% |
| 50-Day Moving Average | 1,678.26 |
| 200-Day Moving Average | 1,732.32 |
| Relative Strength Index (RSI) | 62.79 |
| Average Volume (20 Days) | 95,070 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mizuho Medy had revenue of JPY 10.82 billion and earned 3.23 billion in profits. Earnings per share was 169.41.
| Revenue | 10.82B |
| Gross Profit | 7.40B |
| Operating Income | 4.17B |
| Pretax Income | 4.45B |
| Net Income | 3.23B |
| EBITDA | 4.44B |
| EBIT | 4.17B |
| Earnings Per Share (EPS) | 169.41 |
Balance Sheet
The company has 13.06 billion in cash and no debt, with a net cash position of 13.06 billion or 685.45 per share.
| Cash & Cash Equivalents | 13.06B |
| Total Debt | n/a |
| Net Cash | 13.06B |
| Net Cash Per Share | 685.45 |
| Equity (Book Value) | 18.55B |
| Book Value Per Share | 974.03 |
| Working Capital | 16.89B |
Cash Flow
In the last 12 months, operating cash flow was 2.69 billion and capital expenditures -238.00 million, giving a free cash flow of 2.45 billion.
| Operating Cash Flow | 2.69B |
| Capital Expenditures | -238.00M |
| Depreciation & Amortization | 274.00M |
| Net Borrowing | n/a |
| Free Cash Flow | 2.45B |
| FCF Per Share | 128.67 |
Margins
Gross margin is 68.40%, with operating and profit margins of 38.53% and 29.83%.
| Gross Margin | 68.40% |
| Operating Margin | 38.53% |
| Pretax Margin | 41.13% |
| Profit Margin | 29.83% |
| EBITDA Margin | 41.06% |
| EBIT Margin | 38.53% |
| FCF Margin | 22.66% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 5.77%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 5.77% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 59.00% |
| Buyback Yield | 20.00% |
| Shareholder Yield | 25.77% |
| Earnings Yield | 9.77% |
| FCF Yield | 7.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 27, 2024. It was a forward split with a ratio of 2.
| Last Split Date | Jun 27, 2024 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Mizuho Medy has an Altman Z-Score of 11.21 and a Piotroski F-Score of 4.
| Altman Z-Score | 11.21 |
| Piotroski F-Score | 4 |